N-[[6-[3-(3-chloro-5-fluorophenyl)-5-fluorophenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;N-[(6-ethynyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;5-[3-[(7-methoxyquinolin-4-yl)oxymethyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methylpyridin-2-one;7-methoxy-N-[[6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine
C107H82ClF5N36O7 — CID 159715386
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[6-[3-(3-chloro-5-fluorophenyl)-5-fluorophenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;N-[(6-ethynyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;5-[3-[(7-methoxyquinolin-4-yl)oxymethyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methylpyridin-2-one;7-methoxy-N-[[6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine
N-[[6-[3-(3-chloro-5-fluorophenyl)-5-fluorophenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;N-[(6-ethynyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;5-[3-[(7-methoxyquinolin-4-yl)oxymethyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methylpyridin-2-one;7-methoxy-N-[[6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine (PubChem CID 159715386) has the molecular formula C107H82ClF5N36O7 and a molecular weight of 2114.52 g/mol. Its IUPAC name is N-[[6-[3-(3-chloro-5-fluorophenyl)-5-fluorophenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;N-[(6-ethynyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;5-[3-[(7-methoxyquinolin-4-yl)oxymethyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methylpyridin-2-one;7-methoxy-N-[[6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine.
Molecular Properties
| Compound Name | N-[[6-[3-(3-chloro-5-fluorophenyl)-5-fluorophenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;N-[(6-ethynyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;5-[3-[(7-methoxyquinolin-4-yl)oxymethyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methylpyridin-2-one;7-methoxy-N-[[6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine |
|---|---|
| PubChem CID | 159715386 |
| Molecular Formula | C107H82ClF5N36O7 |
| Molecular Weight | 2114.52 g/mol |
| Exact Mass | 2112.68 |
| IUPAC Name | N-[[6-[3-(3-chloro-5-fluorophenyl)-5-fluorophenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;N-[(6-ethynyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;5-[3-[(7-methoxyquinolin-4-yl)oxymethyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methylpyridin-2-one;7-methoxy-N-[[6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine |
| SMILES | C#Cc1ccc2nnc(CNc3ccnc4cc(OC)cnc34)n2n1.COc1ccc2c(OCc3nnc4ccc(-c5ccc(=O)n(C)c5)nn34)ccnc2c1.COc1cnc2c(NCc3nnc4ccc(-c5cc(F)cc(-c6cc(F)cc(Cl)c6)c5)nn34)ccnc2c1.COc1cnc2c(NCc3nnc4ccc(-c5cccc(C(F)(F)F)c5)nn34)ccnc2c1.COc1cnc2c(NCc3nnc4ccc(-c5cnn(C)c5)nn34)ccnc2c1 |
| InChI | InChI=1S/C27H18ClF2N7O.C22H16F3N7O.C22H18N6O3.C19H17N9O.C17H13N7O/c1-38-21-12-24-27(33-13-21)23(4-5-31-24)32-14-26-35-34-25-3-2-22(36-37(25)26)17-6-15(8-19(29)10-17)16-7-18(28)11-20(30)9-16;1-33-15-10-18-21(28-11-15)17(7-8-26-18)27-12-20-30-29-19-6-5-16(31-32(19)20)13-3-2-4-14(9-13)22(23,24)25;1-27-12-14(3-8-22(27)29)17-6-7-20-24-25-21(28(20)26-17)13-31-19-9-10-23-18-11-15(30-2)4-5-16(18)19;1-27-11-12(8-23-27)14-3-4-17-24-25-18(28(17)26-14)10-21-15-5-6-20-16-7-13(29-2)9-22-19(15)16;1-3-11-4-5-15-21-22-16(24(15)23-11)10-19-13-6-7-18-14-8-12(25-2)9-20-17(13)14/h2-13H,14H2,1H3,(H,31,32);2-11H,12H2,1H3,(H,26,27);3-12H,13H2,1-2H3;3-9,11H,10H2,1-2H3,(H,20,21);1,4-9H,10H2,2H3,(H,18,19) |
| InChIKey | MZJATEWGGIUQCQ-UHFFFAOYSA-N |
| XLogP | 16.71 |
| TPSA | 474.73 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 156 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2114.52 |
| LogP ≤ 5 | 16.71 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 43 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159715386 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.